Zhejiang Xinguang Pharmaceutical Co Ltd Financial Flexibility Index
Zhejiang Xinguang Pharmaceutical Co Ltd financial flexibility index. Zhejiang Xinguang Pharmaceutical Co Ltd (300519) has a Financial Flexibility Index of -0.04x as of June 2025. Free cash flow of CN¥-2.60 Million (operating CF CN¥-5.00 Million minus capex CN¥2.40 Million) represents 0% of total liabilities (CN¥65.28 Million). See 300519 free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Zhejiang Xinguang Pharmaceutical Co Ltd (2011–2024)
Financial flexibility index of Zhejiang Xinguang Pharmaceutical Co Ltd from 2011 to 2024. Historical Financial Flexibility Index trend for Zhejiang Xinguang Pharmaceutical Co Ltd across 14 annual periods. Check Zhejiang Xinguang Pharmaceutical Co Ltd earnings quality ratio to evaluate the quality of earnings relative to operating cash generation.
Zhejiang Xinguang Pharmaceutical Co Ltd Financial Flexibility Index by Year (2011–2024)
Zhejiang Xinguang Pharmaceutical Co Ltd financial flexibility index by year from 2011 to 2024. Year-by-year free cash flow to debt coverage for Zhejiang Xinguang Pharmaceutical Co Ltd. For the full cash flow conversion analysis, see cash flow conversion of Zhejiang Xinguang Pharmaceutical Co Ltd.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.74x | CN¥58.63 Million | CN¥53.43 Million | CN¥79.25 Million | ▼ -7.8% |
| 2023 | 0.80x | CN¥69.28 Million | CN¥53.29 Million | CN¥86.29 Million | ▼ -44.5% |
| 2022 | 1.45x | CN¥143.07 Million | CN¥126.43 Million | CN¥98.86 Million | ▼ -20.6% |
| 2021 | 1.82x | CN¥157.07 Million | CN¥142.36 Million | CN¥86.19 Million | ▼ -5.3% |
| 2020 | 1.92x | CN¥122.88 Million | CN¥112.61 Million | CN¥63.84 Million | ▲ +3.5% |
| 2019 | 1.86x | CN¥114.26 Million | CN¥98.27 Million | CN¥61.42 Million | ▲ +13.0% |
| 2018 | 1.65x | CN¥114.04 Million | CN¥92.77 Million | CN¥69.24 Million | ▼ -26.3% |
| 2017 | 2.23x | CN¥154.63 Million | CN¥124.23 Million | CN¥69.24 Million | ▼ -5.8% |
| 2016 | 2.37x | CN¥143.45 Million | CN¥121.18 Million | CN¥60.49 Million | ▼ -9.1% |
| 2015 | 2.61x | CN¥139.68 Million | CN¥124.84 Million | CN¥53.52 Million | ▲ +16.1% |
| 2014 | 2.25x | CN¥121.67 Million | CN¥99.82 Million | CN¥54.10 Million | ▲ +53.9% |
| 2013 | 1.46x | CN¥64.73 Million | CN¥57.51 Million | CN¥44.29 Million | ▲ +94.6% |
| 2012 | 0.75x | CN¥56.95 Million | CN¥53.93 Million | CN¥75.82 Million | ▲ +114.8% |
| 2011 | 0.35x | CN¥40.23 Million | CN¥34.40 Million | CN¥115.03 Million | — |